AAAAAA

   
Results: 1-12 |
Results: 12
Anticoagulant therapy for osteonecrosis associated with heritable hypofibrinolysis and thrombophilia
Authors: Glueck, CJ Freiberg, RA Fontaine, RN Sieve-Smith, L Wang, P
Citation: Cj. Glueck et al., Anticoagulant therapy for osteonecrosis associated with heritable hypofibrinolysis and thrombophilia, EXPERT OP I, 10(7), 2001, pp. 1309-1316
Interaction of heritable and estrogen-induced thrombophilia: Possible etiologies for ischemic optic neuropathy and ischemic stroke
Authors: Glueck, CJ Fontaine, RN Wang, P
Citation: Cj. Glueck et al., Interaction of heritable and estrogen-induced thrombophilia: Possible etiologies for ischemic optic neuropathy and ischemic stroke, THROMB HAEM, 85(2), 2001, pp. 256-259
Genetic hypofibrinolysis in complicated pregnancies
Authors: Glueck, CJ Kupferminc, MJ Fontaine, RN Wang, P Weksler, BB Eldor, A
Citation: Cj. Glueck et al., Genetic hypofibrinolysis in complicated pregnancies, OBSTET GYN, 97(1), 2001, pp. 44-48
Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30
Authors: Glueck, CJ Fontaine, RN Wang, P Subbiah, MTR Weber, K Illig, E Streicher, P Sieve-Smith, L Tracy, TM Lang, JE McCullough, P
Citation: Cj. Glueck et al., Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30, METABOLISM, 50(7), 2001, pp. 856-861
Interaction of estrogen replacement therapy with the thrombophilic 20210 G/A prothrombin gene mutation for atherothrombotic vascular disease: A cross-sectional study of 275 hyperlipidemic women
Authors: Glueck, CJ Wang, P Fontaine, RN Sieve-Smith, L Lang, JE
Citation: Cj. Glueck et al., Interaction of estrogen replacement therapy with the thrombophilic 20210 G/A prothrombin gene mutation for atherothrombotic vascular disease: A cross-sectional study of 275 hyperlipidemic women, METABOLISM, 50(3), 2001, pp. 360-365
Hypofibrinolysis, thrombophilia, osteonecrosis
Authors: Glueck, CJ Freiberg, RA Fontaine, RN Tracy, T Wang, P
Citation: Cj. Glueck et al., Hypofibrinolysis, thrombophilia, osteonecrosis, CLIN ORTHOP, (386), 2001, pp. 19-33
The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: An independent risk factor for serious pregnancy complications
Authors: Glueck, CJ Phillips, H Cameron, D Wang, P Fontaine, RN Moore, SK Sieve-Smith, L Tracy, T
Citation: Cj. Glueck et al., The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: An independent risk factor for serious pregnancy complications, METABOLISM, 49(7), 2000, pp. 845-852
Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage
Authors: Glueck, CJ Awadalla, SG Phillips, H Cameron, D Wang, P Fontaine, RN
Citation: Cj. Glueck et al., Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage, FERT STERIL, 74(2), 2000, pp. 394-397
Plasminogen activator inhibitor activity: An independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome
Authors: Glueck, CJ Wang, P Fontaine, RN Sieve-Smith, L Tracy, T Moore, SK
Citation: Cj. Glueck et al., Plasminogen activator inhibitor activity: An independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome, METABOLISM, 48(12), 1999, pp. 1589-1595
The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis
Authors: Glueck, CJ Fontaine, RN Gruppo, R Stroop, D Sieve-Smith, L Tracy, T Wang, P
Citation: Cj. Glueck et al., The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis, CLIN ORTHOP, (366), 1999, pp. 133-146
Heritable thrombophilia and hypofibrinolysis - Possible causes of retinal vein occlusion
Authors: Glueck, CJ Bell, H Vadlamani, L Gupta, A Fontaine, RN Wang, P Stroop, D Gruppo, R
Citation: Cj. Glueck et al., Heritable thrombophilia and hypofibrinolysis - Possible causes of retinal vein occlusion, ARCH OPHTH, 117(1), 1999, pp. 43-49
Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the Factor V Leiden mutation (resistanceto activated protein C)
Authors: Glueck, CJ Wang, P Fontaine, RN Tracy, T Sieve-Smith, L Lang, JE
Citation: Cj. Glueck et al., Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the Factor V Leiden mutation (resistanceto activated protein C), AM J CARD, 84(5), 1999, pp. 549-554
Risultati: 1-12 |